ENTRY       D03740                      Drug
NAME        Dextroamphetamine (USAN);
            Dexamfetamine (INN);
            Xelstrym (TN)
PRODUCT     XELSTRYM (Noven Therapeutics)
FORMULA     C9H13N
EXACT_MASS  135.1048
MOL_WEIGHT  135.2062
CLASS       Neuropsychiatric agent
             DG03085  Selective norepinephrine reuptake inhibitor (NRI)
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
REMARK      Same as: C07884
            ATC code: N06BA02
            Chemical structure group: DG00967
            Product (DG00967): D03740<US> D02078<US>
EFFICACY    Stimulant (central)
  DISEASE   Attention deficit hyperactivity disorder [DS:H01895]
COMMENT     Compoment of Biphetamine (TN)
TARGET      SLC18A2 (VMAT2) [HSA:6571] [KO:K08155]
            SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
            SLC6A3 (DAT1) [HSA:6531] [KO:K05036]
  PATHWAY   hsa04721(6530+6531+6571)  Synaptic vesicle cycle
            hsa04726(6571)  Serotonergic synapse
            hsa04728(6531+6571)  Dopaminergic synapse
            hsa05031(6531+6571)  Amphetamine addiction
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07234  Neurotransmitter transporter inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
                N06BA Centrally acting sympathomimetics
                 N06BA02 Dexamfetamine
                  D03740  Dextroamphetamine (USAN) &lt;US&gt;
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03085  Selective norepinephrine reuptake inhibitor (NRI)
               DG00967  Dexamfetamine
                D03740  Dextroamphetamine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00967  Dexamfetamine
                D03740  Dextroamphetamine
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (NAT1)
                 D03740  Dextroamphetamine (USAN) &lt;US&gt;
                SLC6A3 (DAT1)
                 D03740  Dextroamphetamine (USAN) &lt;US&gt;
               SLC18
                SLC18A2 (VMAT2)
                 D03740  Dextroamphetamine (USAN) &lt;US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D03740
            Prodrugs [br08324.html]
             D03740
            Narcotics and psychotropics in Japan [br08308.html]
             Stimulants by Control Act Article 2 Appended Table and Cabinet Order
              D03740
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03085  Selective norepinephrine reuptake inhibitor (NRI)
               DG00967  Dexamfetamine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00967  Dexamfetamine
DBLINKS     CAS: 51-64-9
            PubChem: 17397829
            ChEBI: 4469
            PDB-CCD: 1WE
            LigandBox: D03740
            NIKKAJI: J4.121A
ATOM        10
            1   C8y C    18.0875  -15.2739
            2   C8x C    16.8262  -14.5732
            3   C8x C    18.0875  -16.6754
            4   C1b C    19.2786  -14.5732
            5   C8x C    15.6350  -15.2739
            6   C8x C    16.8262  -17.3761
            7   C1c C    20.4698  -15.2739
            8   C8x C    15.6350  -16.6754
            9   N1a N    21.6609  -14.5732
            10  C1a C    20.4695  -16.6597
BOND        10
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     4   7 1
            7     5   8 2
            8     7   9 1
            9     6   8 1
            10    7  10 1 #Up
///
